Literature DB >> 7622287

EGFR gene amplification--rearrangement in human glioblastomas.

K Schwechheimer1, S Huang, W K Cavenee.   

Abstract

Immunostaining using an affinity-purified rabbit polyclonal antibody against the extracellular domain of the epidermal-growth-factor receptor (EGFR) showed over-expression occurring in a fraction of tumor cells in 17 out of 18 human glioblastomas and in a majority of cells in 7 of the 18. Southern-blotting technique using a full-length EGFR cDNA probe showed a variable degree of amplification in 10 of the 17 glioblastomas, which was associated with EGFR over-expression in each case. In 2 of the glioblastomas with EGFR gene amplification, a rearrangement of the gene affecting the extracellular domain of the receptor was identified and DNA sequence analyses revealed an identical deletion-rearrangement of 801 base pairs between exons 2 to 7, resulting in an in-frame fusion of exons 1 and 8.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622287     DOI: 10.1002/ijc.2910620206

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

2.  Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.

Authors:  Jeonghee Cho; Sandra Pastorino; Qing Zeng; Xiaoyin Xu; William Johnson; Scott Vandenberg; Roel Verhaak; Andrew D Cherniack; Hideo Watanabe; Amit Dutt; Jihyun Kwon; Ying S Chao; Robert C Onofrio; Derek Chiang; Yuki Yuza; Santosh Kesari; Matthew Meyerson
Journal:  Cancer Res       Date:  2011-10-14       Impact factor: 12.701

3.  Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR.

Authors:  Xiaogang Pan; Gong Wu; Weiliang Yang; Rolf F Barth; Werner Tjarks; Robert J Lee
Journal:  Bioconjug Chem       Date:  2007 Jan-Feb       Impact factor: 4.774

4.  Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.

Authors:  Marc Hens; Ganesan Vaidyanathan; Phil Welsh; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2009-02       Impact factor: 2.408

5.  Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.

Authors:  W Yang; R F Barth; R Leveille; D M Adams; M Ciesielski; R A Fenstermaker; J Capala
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

6.  Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.

Authors:  Mohammed S Shazeeb; Christopher H Sotak; Michael DeLeo; Alexei Bogdanov
Journal:  Cancer Res       Date:  2011-01-18       Impact factor: 12.701

Review 7.  Platelet-derived growth factor in human brain tumors.

Authors:  M Kirsch; J C Wilson; P Black
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 8.  Using the molecular classification of glioblastoma to inform personalized treatment.

Authors:  Adriana Olar; Kenneth D Aldape
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

9.  ADAM17 promotes glioma cell malignant phenotype.

Authors:  Xuguang Zheng; Feng Jiang; Mark Katakowski; Yong Lu; Michael Chopp
Journal:  Mol Carcinog       Date:  2011-04-07       Impact factor: 4.784

10.  Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

Authors:  Okezie O Kanu; Betsy Hughes; Chunhui Di; Ningjing Lin; Jinrong Fu; Darell D Bigner; Hai Yan; Cory Adamson
Journal:  Clin Med Oncol       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.